Oligo and Peptide Therapeutics 2018: State of the Industry Report
Download the exclusive research report now
The oligo and peptide therapeutics industry is at an interesting point. There are both potential opportunities and challenges around therapeutic discovery, clinical trials, manufacturing, delivery, regulations and business acquisitions. KNect365 Life Sciences conducted one of the biggest surveys of its kind across professionals from pharma and biotechs, service providers, CDMOs, academia and regulators around the world.
This report based on 162 responses reveals unique insights into how industry insiders view the state of oligos and peptides in 2018; the hottest potential opportunities; the biggest challenges and how they are tackling them. To introduce the report, Dan Stanton, editor of BioProcess Insider, explores what some of the key takeaways mean for the industry.
To download the exclusive report simply log in or register for a KNect365 account, which will give you access to all our exclusive premium content.
Have any questions about the report or interested in sponsoring a future survey? Email firstname.lastname@example.org.